ArticleCureus2025
High-Grade Undifferentiated Pleomorphic Sarcoma of the Tongue: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Undifferentiated pleomorphic sarcoma (UPS) is a rare entity that mainly affects the extremities and is uncommon in the head and neck region. Arising from mesenchymal cells with complex genomic alterations, its typical clinical presentation involves a rapidly growing mass in elderly patients. Although surgical resection is the main treatment, high rates of recurrence and metastasis are usually present, requiring radiotherapy or chemotherapy as complementary therapies. We present the case of a 75-year-old female patient with a tongue mass, initially diagnosed as a fibrous tumor and subsequently as a high-grade pleomorphic undifferentiated sarcoma of the tongue. After an initial hemiglossectomy and a second surgery with wide excision, reconstruction, and radiotherapy, no evidence of residual disease was observed at follow-up. Despite developing xerostomia and dysarthria as late side effects of treatment, the patient showed a favorable response to treatment, with regular check-ups revealing no tumor activity until 24 months after treatment. This case highlights the importance of a multidisciplinary approach in the management of tongue sarcoma, showing that a combination of surgery, radiotherapy, and close follow-up can result in the successful control of this pathology, even in highly aggressive cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.